Is Weed Legal in Rwanda? Understanding Rwanda Cannabis and Marijuana Laws (2026)

Rwanda allows cannabis activities for medical and research purposes within a strict authorization system. Recreational use and unlicensed personal cultivation remain illegal. The country has pursued an export-oriented industry, but its cannabis order also expressly provides for authorized medical use; export policy should not be confused with a law prohibiting every domestic medical application.

The practical questions are whether the operator, product, prescriber, and activity have the required approvals. A commercial investment announcement does not establish that a facility is producing, and a medical-use provision does not guarantee that a particular treatment is available in pharmacies.

Is Cannabis Legal in Rwanda?

The Ministerial Order relating to Cannabis and Cannabis Products, No. 003/MoH/2021, took effect on June 28, 2021. It establishes rules for cultivation, processing, distribution, and use for medical and research purposes, following Cabinet approval in October 2020.

It does not create an adult-use market or remove cannabis from the drug-control system. Licensed medical or research activity and unlawful recreational activity therefore have very different legal positions.

Which Licenses and Permits Are Required?

Article 5 identifies eight types of authorization: cultivation and processing licenses; separate import and export permits for seeds and planting material; separate import and export permits for cannabis and cannabis products; finished-product registration certificates; and research licenses.

The distinction between a license and a shipment permit is important. Licenses under the order are renewable after five years, but Articles 7 and 10 require a permit for each relevant import or export. A five-year cultivation license is not a five-year unrestricted border permit.

Only a cultivation-license holder may apply to import or export seeds, genetic material, and other planting stock. A processing-license holder must also register each type of finished product. Operations must take place at licensed establishments or other locations approved by the competent authority.

The government’s Irembo cultivation-license guidance identifies RICA, the Rwanda Inspectorate, Competition and Consumer Protection Authority, as the issuing authority for that service and describes a site inspection. Applicants should follow the requirements for their actual activity rather than assuming one approval covers the entire supply chain.

Can Patients Obtain Medical Cannabis?

Article 14 permits medical use only when prescribed by a specialist medical doctor. The order defines that doctor as one authorized in writing by the Ministry of Health to prescribe cannabis and cannabis products. An ordinary prescription from a doctor without that authorization does not satisfy the stated requirement.

That legal route is different from demonstrating routine retail availability. The sources reviewed for this guide do not establish a nationwide pharmacy-access program or identify a universally available cannabis medicine. Patients should confirm the current product authorization, authorized prescriber, and lawful dispensing route with the Ministry of Health and Rwanda FDA.

It is inaccurate to conclude that all domestic medical use is illegal merely because investment has focused on exports. It is equally inaccurate to promise access simply because the order permits prescriptions. Product availability and individual authorization require separate confirmation.

Is Recreational Cannabis Legal?

No. Rwanda has not created a recreational possession exemption, a personal-use retail market, or a tourist exception through its medical cannabis order. Unauthorized possession, consumption, supply, and cultivation can result in criminal proceedings.

A medical cannabis card issued elsewhere does not establish compliance with Rwanda’s prescribing, product, and import requirements. Travelers should obtain confirmation from the relevant Rwandan authorities before bringing a cannabis-derived medicine into the country.

Can You Grow Cannabis at Home?

The order provides no general home-growing allowance for patients or recreational consumers. Cultivation must be authorized, undertaken for the permitted purposes, and conducted at approved premises.

Operators must submit a security plan to the Rwanda National Police. Required measures include double-layer fencing, controlled access, surveillance, intrusion detection, and licensed private security. The order assigns the inner security layer to the operator and its security provider, with middle and outer layers assigned to the police.

Transport, records, and traceability are also regulated. These obligations demonstrate why permission to produce medical cannabis cannot be interpreted as permission to plant it privately without a license.

What Are the Penalties?

Article 263 of the general offences law was amended by Law 69/2019. Its personal possession/use provision specifies one to two years of imprisonment or community service. The older description of one to three years plus a 50,000-to-500,000-franc fine should not be used for that amended provision.

Unlawful production, transport, storage, supply, and sale fall under much more severe provisions. Cannabis is classified among the most strictly controlled drugs in the 2019 categorization order. Article 263 includes life imprisonment for the highest drug category, with additional provisions concerning children and international activity. A specific charge and sentence depend on the conduct, applicable provisions, and court proceedings.

Licensed operators face a separate administrative regime. Article 20 of the cannabis order provides fines of one million to fifty million Rwandan francs for violations of license conditions, doubled for repeat violations. Suspension or revocation can also apply. Those business sanctions should not be confused with the penalties for unlawful personal use.

What Is Happening With Rwanda’s Export Industry?

Rwanda has sought investment in controlled medicinal-cannabis production, but announced projects must be distinguished from operating facilities and completed exports. King Kong Organics, or KKOG Rwanda, received an early five-year license in 2024 and announced a production facility in Musanze.

More recent reporting by The New Times on July 27, 2026 described the project as stalled, citing the company’s chief executive on funding and land-title difficulties. Those are attributed company claims, not findings that resolve responsibility for the delay. The old May 2025 construction-progress percentage is therefore not a reliable description of current operating status.

The same report covered Cabinet approval of a concession agreement with InipasvalleyRw Ltd for a high-value therapeutic crops project. It explicitly said the publication had not confirmed whether that concession was specifically for medical cannabis. It should not be counted as a confirmed new cannabis operation on that evidence alone.

Is CBD Legal in Rwanda?

The 2021 order regulates cannabis products, including concentrates and preparations, within the medical and research framework. It does not establish a general consumer exemption based simply on a CBD label or low THC content.

A CBD oil, cosmetic, edible, or imported medicine needs a product-specific assessment. Consumers should confirm classification and authorization with Rwanda FDA rather than assume that a product sold legally abroad may be sold or used freely in Rwanda. Authorized medical access and unrestricted over-the-counter commerce are different questions.

How Does Rwanda Compare With Other African Countries?

Countries including Morocco, Zimbabwe, and Malawi have developed their own regulated cannabis sectors. Their cultivation, patient-access, and industrial rules cannot be transferred to Rwanda.

For Rwanda, the central distinction is between authorized medical and research activity and prohibited recreational activity. Prospective operators need the relevant licenses and shipment permissions; patients need an authorized medical pathway. Neither an export ambition nor a private medical need removes those requirements.